What We're Reading: Page 287
Industry reads hand-picked by our editors
Feb 06, 2018
-
Reuters
In diabetes war, Novo Nordisk aims to break mold with new pill
-
Financial Times
How DNA could store all the world’s data in a semi-trailer
-
MIT Technology Review
A biotech CEO explains why he injected himself with a DIY herpes treatment live on stage
-
The Wall Street Journal
Why Sanofi and its rivals are paying up for deals
Feb 05, 2018
Feb 02, 2018
-
The Denver Post
Big pharma may own Washington, but it doesn't own Amazon
-
Bloomberg
Fosun's $1.5 billion biotech arm mulls Hong Kong IPO
-
Wired
Could a vaccine protect football players from concussions?
-
CNBC
Pharma's latest defense: Drugs lower health-care costs
-
Forbes
Blockchain technologies poised to disrupt stagnant trial timelines
Feb 01, 2018
-
Bloomberg Gadfly
AbbVie is ruining pharma earnings season
-
Wired
Big pharma has the flu
-
Scientific American
A big step toward a blood test for Alzheimer's
Jan 31, 2018
-
Kaiser Health News
Expert advice for the corporate titans taking on health care
-
Fortune
Female founders got 2% of venture capital dollars in 2017
-
The Wall Street Journal
Investor who rode pivot from biotech to Bitcoin sells big stake
-
The New York Times
Preventive care saves money? Sorry, it’s too good to be true
Jan 30, 2018
Jan 29, 2018
-
Reuters
How Sanofi's setback could lead to better dengue vaccines
-
Bloomberg
Hong Kong seeks to cash in on frenzy for Chinese drug stocks
-
Chemical & Engineering News
Uncovering the hidden signs of organ transplant rejection
Previous
